Literature DB >> 20020229

Salmonella enteritidis necrotising fasciitis in a multiple myeloma patient receiving bortezomib.

Andrew Rosser, Gillian Swallow, R Andrew Swann, Claire Chapman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20020229     DOI： 10.1007/s12185-009-0463-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  10 in total

Review 1.  Bortezomib: a valuable new antineoplastic strategy in multiple myeloma.

Authors:  Joan Bladé; M Teresa Cibeira; Laura Rosiñol
Journal:  Acta Oncol       Date:  2005       Impact factor: 4.089

Review 2.  Biology and treatment of multiple myeloma.

Authors:  Patrizia Tosi; Barbara Gamberi; Nicola Giuliani
Journal:  Biol Blood Marrow Transplant       Date:  2006-01       Impact factor: 5.742

3.  Bortezomib plus melphalan and prednisone for multiple myeloma.

Authors:  Masaharu Tsubokura; Masahiro Kami; Tsunehiko Komatsu
Journal:  N Engl J Med       Date:  2008-12-11       Impact factor: 91.245

4.  Necrotizing fasciitis.

Authors:  B WILSON
Journal:  Am Surg       Date:  1952-04       Impact factor: 0.688

5.  Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

Authors:  S Broder; R Humphrey; M Durm; M Blackman; B Meade; C Goldman; W Strober; T Waldmann
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

6.  Influence of ciprofloxacin resistance on risk factors for endovascular infection in patients with infection due to group C nontyphoid salmonellae.

Authors:  Ron-Bin Hsu; Robert J Chen; Fang-Yue Lin; Shu-Hsun Chu
Journal:  Clin Infect Dis       Date:  2005-03-24       Impact factor: 9.079

Review 7.  Nontyphoidal salmonellosis.

Authors:  E L Hohmann
Journal:  Clin Infect Dis       Date:  2001-01-15       Impact factor: 9.079

8.  Selectively reduced intracellular proliferation of Salmonella enterica serovar typhimurium within APCs limits antigen presentation and development of a rapid CD8 T cell response.

Authors:  Homam Albaghdadi; Nirmal Robinson; Brett Finlay; Lakshmi Krishnan; Subash Sad
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

9.  The proteasome inhibitor bortezomib enhances the susceptibility to viral infection.

Authors:  Michael Basler; Christoph Lauer; Ulrike Beck; Marcus Groettrup
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

Review 10.  Salmonella group C necrotizing fasciitis: a case report and review of the literature.

Authors:  Thana Khawcharoenporn; Anucha Apisarnthanarak; Pattarachai Kiratisin; Linda M Mundy
Journal:  Diagn Microbiol Infect Dis       Date:  2006-02-08       Impact factor: 2.803
  10 in total
  2 in total

1.  Necrotising fasciitis after bortezomib and dexamethasone-containing regimen in an elderly patient of Waldenström macroglobulinaemia.

Authors:  Tomohiro Morita; Tomotaka Ugai; Tetsuya Tanimoto; Kosei Matsue
Journal:  BMJ Case Rep       Date:  2014-03-26

2.  A Case of Rituximab-Induced Necrotizing Fasciitis and a Review of the Literature.

Authors:  Abdullateef Abdulkareem; Ryan S D'Souza; Oluwaseun Shogbesan; Anthony Donato
Journal:  Case Rep Hematol       Date:  2017-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.